RTW Biotech Opportunities (RTW) Competitors GBX 1.40 0.00 (-0.21%) As of 08/22/2025 12:05 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RTW vs. MRC, BHMG, ATT, MYI, N91, WWH, VEIL, FEV, PNL, and WTANShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include The Mercantile Investment Trust (MRC), BH Macro GBP (BHMG), Allianz Technology Trust (ATT), Murray International (MYI), Ninety One Group (N91), Worldwide Healthcare (WWH), Vietnam Enterprise (VEIL), Fidelity European Trust (FEV), Personal Assets (PNL), and Witan Investment Trust (WTAN). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Its Competitors The Mercantile Investment Trust BH Macro GBP Allianz Technology Trust Murray International Ninety One Group Worldwide Healthcare Vietnam Enterprise Fidelity European Trust Personal Assets Witan Investment Trust The Mercantile Investment Trust (LON:MRC) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment. Does the media prefer MRC or RTW? In the previous week, The Mercantile Investment Trust had 1 more articles in the media than RTW Biotech Opportunities. MarketBeat recorded 1 mentions for The Mercantile Investment Trust and 0 mentions for RTW Biotech Opportunities. The Mercantile Investment Trust's average media sentiment score of 1.68 beat RTW Biotech Opportunities' score of 1.14 indicating that The Mercantile Investment Trust is being referred to more favorably in the media. Company Overall Sentiment The Mercantile Investment Trust Very Positive RTW Biotech Opportunities Positive Which has more volatility and risk, MRC or RTW? The Mercantile Investment Trust has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Which has higher valuation and earnings, MRC or RTW? RTW Biotech Opportunities has higher revenue and earnings than The Mercantile Investment Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than The Mercantile Investment Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Mercantile Investment Trust£415.73M4.51£393.55M£53.194.75RTW Biotech Opportunities£2.12B0.22£14.09B£0.423.34 Is MRC or RTW more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to The Mercantile Investment Trust's net margin of 94.67%. RTW Biotech Opportunities' return on equity of 25.18% beat The Mercantile Investment Trust's return on equity.Company Net Margins Return on Equity Return on Assets The Mercantile Investment Trust94.67% 20.56% 2.53% RTW Biotech Opportunities 664.38%25.18%-0.47% Do institutionals & insiders believe in MRC or RTW? 48.8% of The Mercantile Investment Trust shares are owned by institutional investors. Comparatively, 3.9% of RTW Biotech Opportunities shares are owned by institutional investors. 1.7% of The Mercantile Investment Trust shares are owned by insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryThe Mercantile Investment Trust beats RTW Biotech Opportunities on 8 of the 13 factors compared between the two stocks. Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£470.28M£1.31B£6.48B£3.22BDividend YieldN/A4.41%4.18%5.04%P/E Ratio3.3422.7214.42164.64Price / Sales0.222,485.531,790.85310,107.82Price / Cash0.3260.62127.2027.93Price / Book0.011.425.135.90Net Income£14.09B£265.04M£1.23B£5.89B7 Day PerformanceN/A0.61%0.91%48.38%1 Month Performance8.53%0.84%2.17%55.09%1 Year PerformanceN/A6.77%24.12%135.38% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.40-0.2%N/A-9.7%£470.28M£2.12B3.344,971News CoveragePositive NewsMRCThe Mercantile Investment TrustN/AGBX 252.56+0.6%N/A+0.8%£1.87B£415.73M4.752,800Positive NewsBHMGBH Macro GBPN/AGBX 394.61-0.4%N/A+9.1%£1.82B£35.67M42.61N/AATTAllianz Technology TrustN/AGBX 463.24-0.6%N/A+24.2%£1.76B£511.77M3.50N/APositive NewsMYIMurray InternationalN/AGBX 292.41+0.3%N/A+16.9%£1.74B£198.15M9.72N/ANews CoverageEarnings ReportDividend AnnouncementN91Ninety One Group1.5977 of 5 starsGBX 194.50+0.2%GBX 190-2.3%+18.2%£1.72B£586.81M11.201,180Gap UpWWHWorldwide HealthcareN/AGBX 318.61+0.8%N/A-8.7%£1.70B£245.62M7.42N/APositive NewsHigh Trading VolumeVEILVietnam EnterpriseN/AGBX 728+0.8%N/A+27.4%£1.67B£17.87M-491.71N/ANews CoverageFEVFidelity European TrustN/AGBX 397.31-0.3%N/A+1.9%£1.63B£221.98M7.88N/ANews CoveragePNLPersonal AssetsN/AGBX 510-0.2%N/A+6.3%£1.63B£107.31M13.00N/AWTANWitan Investment TrustN/AN/AN/AN/A£1.58B£246.38M738.896 Related Companies and Tools Related Companies MRC Alternatives BHMG Alternatives ATT Alternatives MYI Alternatives N91 Alternatives WWH Alternatives VEIL Alternatives FEV Alternatives PNL Alternatives WTAN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RTW) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access